Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Account Payables (2022)

Orchestra BioMed Holdings (OBIO) has disclosed Change in Account Payables for 1 consecutive years, with $95369.0 as the latest value for Q4 2022.

  • Quarterly Change in Account Payables changed N/A to $95369.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $375542.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $375542.0 for FY2022, 3123.2% up from the prior year.
  • Change in Account Payables for Q4 2022 was $95369.0 at Orchestra BioMed Holdings, down from $110904.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $110904.0 in Q3 2022, with the low at $67050.0 in Q2 2022.